PureCycle Technologies EPS PCT
Diluted earnings per share by quarter and over the last twelve months, from 2020.
- Last 12 months, to Jun 30, 2026
- −$1.45
- Latest quarter, Q2 FY26
- −$0.80
- Fiscal year 2025
- −$1.20
PureCycle Technologies' earnings per share was −$1.45 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.80.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$1.20 | n/a |
| FY2024 | −$1.74 | n/a |
| FY2023 | −$0.65 | n/a |
| FY2022 | −$0.55 | n/a |
| FY2021 | −$0.94 | n/a |
| FY2020 | −$1.73 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.80 | n/a | −$1.45 | |
| Q1 FY26 | −$0.21 | −520% | −$1.46 | |
| Q4 FY25 | −$0.13 | n/a | −$1.20 | |
| Q3 FY25 | −$0.31 | n/a | −$1.46 | |
| Q2 FY25 | −$0.81 | n/a | −$1.69 | |
| Q1 FY25 | $0.05 | n/a | −$1.17 | |
| Q4 FY24 | −$0.39 | n/a | −$1.74 | |
| Q3 FY24 | −$0.54 | −1900% | −$1.53 | |
| Q2 FY24 | −$0.29 | n/a | −$0.96 | |
| Q1 FY24 | −$0.52 | n/a | −$1.01 | |
| Q4 FY23 | −$0.18 | n/a | −$0.65 | |
| Q3 FY23 | $0.03 | n/a | −$0.53 |
Against its peers
Companies in Chemicals nearest PureCycle Technologies' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| PCTPureCycle Technologies | −$1.45 | |
| FTKFlotek Industries | $0.99 | +125% a year |
| CRONCronos | $0.20 | +300% a year |
| NAGENiagen Bioscience | $0.18 | −14% a year |
| ROGRogers | $1.75 | |
| NGVTIngevity | $1.47 | |
| IOSPInnospec | $4.90 | +545% a year |
| FULFuller H B | $3.59 | +72% a year |
| WDFCWD 40 | $6.58 | +4% a year |
| AVNTAvient | $1.85 | +43% a year |
| CBTCabot | $3.54 | −54% a year |
| Peer median | $1.80 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on PureCycle Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.